Pharmacology and Toxicology
-
Tyrosine Kinase Inhibitor Family of Drugs as Prospective Targeted Therapy for COVID-19 Based on In Silico And 3D-Human Vascular Lung Model Studies
This article has 9 authors:Reviewed by ScreenIT
-
In silico and in vitro Demonstration of Homoharrintonine’s Antagonism of RBD-ACE2 Binding and its Anti-inflammatory and anti-thrombogenic Properties in a 3D human vascular lung model
This article has 9 authors:Reviewed by ScreenIT
-
Mathematical analysis and topology of SARS-CoV-2, bonding with cells and unbonding
This article has 2 authors:Reviewed by ScreenIT
-
ProLung ™- budesonide Inhibits SARS-CoV-2 Replication and Reduces Lung Inflammation
This article has 10 authors:Reviewed by ScreenIT
-
Ribavirin shows antiviral activity against SARS-CoV-2 and downregulates the activity of TMPRSS2 and the expression of ACE2 in vitro
This article has 22 authors:Reviewed by ScreenIT
-
Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction in vitro
This article has 4 authors:Reviewed by ScreenIT
-
Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein–Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2
This article has 7 authors:Reviewed by ScreenIT
-
In vivo pharmacokinetic study of remdesivir dry powder for inhalation in hamsters
This article has 8 authors:Reviewed by ScreenIT
-
Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models
This article has 16 authors:Reviewed by ScreenIT
-
A comparison of Remdesivir versus Au 22 Glutathione 18 in COVID-19 golden hamsters: a better therapeutic outcome of gold compound
This article has 22 authors:Reviewed by ScreenIT